ArticleScience advances2020

Pretargeted delivery of PI3K/mTOR small-molecule inhibitor-loaded nanoparticles for treatment of non-Hodgkin's lymphoma.

Kin Man Au et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.